Position in MYGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$252,182
+$122,735 QoQ
Shares Held
44,165
+53.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 196 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quadrature Capital Ltd holds $65,481,433 across 19 Diagnostics & Research names. MYGN ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
79,969 | $21,707,585 | |
| 2 | GH |
Guardant Health, Inc.
|
63,165 | $9,476,644 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
6,137 | $7,840,078 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
15,383 | $7,712,420 | |
| 5 | RVTY |
Revvity, Inc.
|
48,540 | $5,400,560 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
7,697 | $4,076,254 | |
| 7 | ICLR |
Icon PLC
|
13,531 | $2,350,470 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
20,422 | $1,401,970 |
All Filings in MYGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,182 | 44,165 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $129,447 | 28,766 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||